KRAS G12D-PROTAC (Huadong Medicine)

N/A

Report date: 2023/12/26 16:02:51
NME

Base Information

Drug NameKRAS G12D-PROTAC (Huadong Medicine)
Drug Alias NameN/A
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionKRAS G12D degraders
TargetsKRAS G12D
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHuadong Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHuadong Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A